European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, October 2026

Oncology drug tenders in Portugal in October 2026: 119 tenders published (-78% month on month, -38% year on year), estimated at €591,423 in total, and 100 contracts awarded (-78% month on month, -48% year on year), worth €2,834,433 (contract value). Buyers with the most tenders: Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (25), Unidade Local de Saúde da Região de Leiria, E. P. E. (19) and Unidade Local de Saúde de Castelo Branco, EPE (15); most contracts won: Generis – Farmaceutica, S.A. (8), B Braun Medical Unipessoal, Lda (5) and Hikma Farmacêutica (Portugal) Sa. (5). On average 29.1 bids per contract; 0% of contracts had a single bid. Report made on 8 November 2026.

Tenders published
119
Contracts awarded
100
Contract value contract
€2,834,433
Bids per contract
29.1
Tenders published per month
05001K1.5K2KOct 25: 193Oct 25: 193Oct 25Nov 25: 328Nov 25: 328Nov 25Dec 25: 317Dec 25: 317Dec 25Jan 26: 875Jan 26: 875Jan 26Feb 26: 1,817Feb 26: 1,817Feb 26Mar 26: 394Mar 26: 394Mar 26Apr 26: 1,193Apr 26: 1,193Apr 26May 26: 1,452May 26: 1,452May 26Jun 26: 551Jun 26: 551Jun 26Jul 26: 403Jul 26: 403Jul 26Aug 26: 307Aug 26: 307Aug 26Sep 26: 545Sep 26: 545Sep 26Oct 26: 119Oct 26: 119119Oct 26
Contracts awarded per month
05001K1.5KOct 25: 194Oct 25: 194Oct 25Nov 25: 317Nov 25: 317Nov 25Dec 25: 484Dec 25: 484Dec 25Jan 26: 1,285Jan 26: 1,285Jan 26Feb 26: 1,363Feb 26: 1,363Feb 26Mar 26: 467Mar 26: 467Mar 26Apr 26: 1,432Apr 26: 1,432Apr 26May 26: 1,126May 26: 1,126May 26Jun 26: 511Jun 26: 511Jun 26Jul 26: 337Jul 26: 337Jul 26Aug 26: 330Aug 26: 330Aug 26Sep 26: 460Sep 26: 460Sep 26Oct 26: 100Oct 26: 100100Oct 26

The highlighted bar is October 2026. Hover a bar for its figure; the table below has every value.

FigureOctober 2026September 2026ChangeOctober 2025Change
Tenders published119545-78%193-38%
Estimated value€591,423——€6,290,455-91%
Buyers1925-24%24-21%
Contracts awarded100460-78%194-48%
Contract value (contract)€2,834,433€43,857,686-94%€37,003,880-92%
Winners3659-39%44-18%
Bids per contract29.125.5—13.4—
Single-bid contracts0%0%—15%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Norte 1

Procedures

  • not stated 118
  • Open procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in October 2026?
119 (by 19 buyers); for comparison, September 2026: 545, October 2025: 193.
Who won the most oncology drug tenders in Portugal in October 2026?
By number of contracts: Generis – Farmaceutica, S.A. (8), B Braun Medical Unipessoal, Lda (5), Hikma Farmacêutica (Portugal) Sa. (5), Bristol - Myers Squibb Sa. (5) and Teva Pharma - Produtos Farmaceuticos,lda (4); 36 companies won contracts in all.
Which buyers published the most oncology drug tenders in October 2026?
Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (25), Unidade Local de Saúde da Região de Leiria, E. P. E. (19), Unidade Local de Saúde de Castelo Branco, EPE (15), Unidade Local de Saúde de Santo António, E. P. E. (9) and Unidade Local de Saúde de Santa Maria, E. P. E. (7).
How competitive were oncology drug tenders in Portugal in October 2026?
On average 29.1 bids per contract (27 contracts with a known number of bids); 0% of contracts had a single bid.
What were the contracts worth in October 2026?
€2,834,433 (contract value, 100 contracts); median about €4,900.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 8 November 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.